Cargando…
The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy
Immunosuppressive drugs are widely used to treat several autoimmune disorders and prevent rejection after organ transplantation. However, intra-individual variations in the pharmacological response to immunosuppressive therapy critically influence its efficacy, often resulting in poor treatment resp...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868528/ https://www.ncbi.nlm.nih.gov/pubmed/33569062 http://dx.doi.org/10.3389/fimmu.2020.618202 |
_version_ | 1783648468630241280 |
---|---|
author | Portoles, Jose Maria Jimenez, Carlos Janeiro, Dario Lopez-Oliva, Maria O. Ortega-Carrion, Alvaro Blanquez, Daniel Arribas, Luis Gomez, Carlos Diez, Teresa Pascual, Julio Portero, Isabel |
author_facet | Portoles, Jose Maria Jimenez, Carlos Janeiro, Dario Lopez-Oliva, Maria O. Ortega-Carrion, Alvaro Blanquez, Daniel Arribas, Luis Gomez, Carlos Diez, Teresa Pascual, Julio Portero, Isabel |
author_sort | Portoles, Jose Maria |
collection | PubMed |
description | Immunosuppressive drugs are widely used to treat several autoimmune disorders and prevent rejection after organ transplantation. However, intra-individual variations in the pharmacological response to immunosuppressive therapy critically influence its efficacy, often resulting in poor treatment responses and serious side effects. Effective diagnostic tools that help clinicians to tailor immunosuppressive therapy to the needs and immunological profile of the individual patient thus constitute a major unmet clinical need. In vitro assays that measure immune cell responses to immunosuppressive drugs constitute a promising approach to individualized immunosuppressive therapy. Here, we present the Immunobiogram, a functional pharmacodynamic immune cell-based assay for simultaneous quantitative measurement of a patient’s immune response to a battery of immunosuppressive drugs. Peripheral blood mononuclear cells collected from patients are immunologically stimulated to induce activation and proliferation and embedded in a hydrogel mixture in which they are exposed to a concentration gradient of the immunosuppressants of interest. Analysis of samples from kidney transplant patients using this procedure revealed an association between the sensitivity of individual patients to the immunosuppressive regimen and their immunological risk of transplant rejection. Incorporation of the Immunobiogram assay into clinical settings could greatly facilitate personalized optimization and monitoring of immunosuppressive therapy, and study of the mechanisms underlying resistance to immunosuppressants. |
format | Online Article Text |
id | pubmed-7868528 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78685282021-02-09 The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy Portoles, Jose Maria Jimenez, Carlos Janeiro, Dario Lopez-Oliva, Maria O. Ortega-Carrion, Alvaro Blanquez, Daniel Arribas, Luis Gomez, Carlos Diez, Teresa Pascual, Julio Portero, Isabel Front Immunol Immunology Immunosuppressive drugs are widely used to treat several autoimmune disorders and prevent rejection after organ transplantation. However, intra-individual variations in the pharmacological response to immunosuppressive therapy critically influence its efficacy, often resulting in poor treatment responses and serious side effects. Effective diagnostic tools that help clinicians to tailor immunosuppressive therapy to the needs and immunological profile of the individual patient thus constitute a major unmet clinical need. In vitro assays that measure immune cell responses to immunosuppressive drugs constitute a promising approach to individualized immunosuppressive therapy. Here, we present the Immunobiogram, a functional pharmacodynamic immune cell-based assay for simultaneous quantitative measurement of a patient’s immune response to a battery of immunosuppressive drugs. Peripheral blood mononuclear cells collected from patients are immunologically stimulated to induce activation and proliferation and embedded in a hydrogel mixture in which they are exposed to a concentration gradient of the immunosuppressants of interest. Analysis of samples from kidney transplant patients using this procedure revealed an association between the sensitivity of individual patients to the immunosuppressive regimen and their immunological risk of transplant rejection. Incorporation of the Immunobiogram assay into clinical settings could greatly facilitate personalized optimization and monitoring of immunosuppressive therapy, and study of the mechanisms underlying resistance to immunosuppressants. Frontiers Media S.A. 2021-01-25 /pmc/articles/PMC7868528/ /pubmed/33569062 http://dx.doi.org/10.3389/fimmu.2020.618202 Text en Copyright © 2021 Portoles, Jimenez, Janeiro, Lopez-Oliva, Ortega-Carrion, Blanquez, Arribas, Gomez, Diez, Pascual and Portero http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Portoles, Jose Maria Jimenez, Carlos Janeiro, Dario Lopez-Oliva, Maria O. Ortega-Carrion, Alvaro Blanquez, Daniel Arribas, Luis Gomez, Carlos Diez, Teresa Pascual, Julio Portero, Isabel The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy |
title | The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy |
title_full | The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy |
title_fullStr | The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy |
title_full_unstemmed | The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy |
title_short | The Immunobiogram, a Novel In Vitro Assay to Evaluate Treatment Resistance in Patients Receiving Immunosuppressive Therapy |
title_sort | immunobiogram, a novel in vitro assay to evaluate treatment resistance in patients receiving immunosuppressive therapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868528/ https://www.ncbi.nlm.nih.gov/pubmed/33569062 http://dx.doi.org/10.3389/fimmu.2020.618202 |
work_keys_str_mv | AT portolesjosemaria theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT jimenezcarlos theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT janeirodario theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT lopezolivamariao theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT ortegacarrionalvaro theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT blanquezdaniel theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT arribasluis theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT gomezcarlos theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT diezteresa theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT pascualjulio theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT porteroisabel theimmunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT portolesjosemaria immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT jimenezcarlos immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT janeirodario immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT lopezolivamariao immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT ortegacarrionalvaro immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT blanquezdaniel immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT arribasluis immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT gomezcarlos immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT diezteresa immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT pascualjulio immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy AT porteroisabel immunobiogramanovelinvitroassaytoevaluatetreatmentresistanceinpatientsreceivingimmunosuppressivetherapy |